Clinical Trial: Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Firstline Therapy for Pediatric Locally Advanced and Metastatic Soft Tissue Sarcoma/Ewing Sarcoma: A Prospective, Singlearm Clinical Study (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Firstline Therapy for Pediatric Locally Advanced and Metastatic Soft Tissue Sarcoma/Ewing Sarcoma: A Prospective, Singlearm Clinical Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132995

Registration Time: 2026/09/20

Type: Interventional study

Primary Sponsor: Beijing Childrens Hospital,Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342923

Published by HT Digital Content Services with permission from Health Daily Digest....